Waters Corporation

NYSE:WAT

Medical - Diagnostics & Research

Healthcare
$466.10 -0.16%

-$0.57 today

Market cap
$45.81B
Beta
1.20
P/E (TTM)
65.2
EPS (TTM)
$5.47
52W Low $275.05High $414.15

Volume 0.73M

Average 1.03M

WAT Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Waters CorporationNYSE: WAT

Stock-Based Compensation · Q2 FY2026 · quarter ended Jul 2026

Stock-based compensation growth accelerates

Q2 FY2026 stock-based compensation of $25M rose 90.9% year over year, ahead of the +51.3% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 25.0% from the prior quarter. Over 3 fiscal years it compounded at +8.3% a year.

Context

  • Stock-based compensation amounted to 1.7% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Stock-based compensation increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +90.9% holds above the trailing-twelve-month pace of +51.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJul 2026
$25M+25.0% QoQ
Last fiscal yearDec 2025
$54.13M+21.1% YoY
LTMJul 2026
$73.15M+51.3% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+90.9%——
1 year+21.1%——
3-year CAGR+8.3%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
54.13M USD
Year-over-year change
+21.1%
4-year CAGR
+16.0%

Stock-Based Compensation vs competitors

How WAT compares with its peers on the latest reported figures

  • WAT's LTM Jul 2026 stock-based compensation of $73.15M is the 4th largest of the 7 companies compared; the peer median is $54.21M.
  • Its year-over-year change of +51.3% is the highest of 6, against a peer median of +1.7%.
  • Stock-based compensation amounts to 1.6% of revenue for WAT, versus a peer median of 0.7%.
WAT Competitors Peer median
Stock-Based Compensation for WAT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DHRDanaher CorporationLTM Sep 2026$297M +1.7%+0.3%1.2%
AAgilent Technologies, Inc.LTM Jul 2026$131M +2.3%+0.8%1.8%
TMOThermo Fisher Scientific Inc.LTM Sep 2026$84M —+0.3%0.2%
WATWaters CorporationLTM Jul 2026$73.15M +51.3%+8.3%1.6%
RVTYRevvity, Inc.LTM Jul 2026$24.43M -27.0%-23.7%0.8%
MTDMettler-Toledo International Inc.LTM Jun 2026$22.83M +7.5%+4.6%0.6%
BRKRBruker CorporationLTM Jun 2026$0 -100.0%-10.0%0.0%
Peer median (excluding WAT) $54.21M+1.7%+0.3%0.7%

Competitors are the stored peer set for WAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income692.84M707.76M642.23M637.83M642.63M
Depreciation & Amortization131.68M130.42M165.91M191.83M206.24M
Deferred Income Tax16.63M(31.99M)(1.2M)(877K)(14.66M)
Stock-Based Compensation29.92M42.56M36.87M44.71M54.13M
Change in Working Capital(107.17M)(269.08M)(240.26M)(111.37M)(233.38M)
Accounts Receivables(62.45M)(137.87M)49.18M(66.24M)(55.5M)
Inventory(67.25M)(101.9M)(45.44M)20.94M(65.93M)
Accounts Payables46.11M60.98M(79.52M)61.59M(89.01M)
Other Working Capital(23.58M)(90.29M)(164.47M)(127.66M)(22.94M)
Other Non-Cash Items(16.63M)31.99M(742K)0(2.4M)
Operating Cash Flow747.27M611.66M602.81M762.12M652.56M
Capital Expenditures(168.27M)(183.46M)(160.63M)(142.48M)(112.75M)
Acquisitions (Net)7M(1.37M)(1.28B)(1.49M)(35.05M)
Purchases of Investments(63.36M)(11.41M)(1.79M)(3.73M)(7.3M)
Sales of Investments218.08M86.9M2.51M3.68M0
Other Investing Activities(225.08M)1.37M002.84M
Investing Cash Flow(231.63M)(107.97M)(1.44B)(144.02M)(152.25M)
Debt Repayment160M60M780M(730M)(243.32M)
Common Stock Issued000020.79M
Common Stock Repurchased(648.93M)(626.06M)(70.28M)(13.54M)(14.67M)
Dividends Paid00000
Other Financing Activities50.66M56.43M45.23M46.87M(7K)
Financing Cash Flow(438.28M)(509.63M)754.95M(696.68M)(237.21M)
Effect of Forex Changes(12.83M)(14.77M)(948K)7.92M(621K)
Net Change in Cash64.54M(20.71M)(85.45M)(70.66M)262.48M
Free Cash Flow579.01M428.21M442.18M619.64M539.81M

Waters Corporation

NYSE:WAT

Intrinsic Alpha fair value

Locked

Current Price

$466.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.